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Abstract: Human variants in plakophilin-2 (PKP2) associate with most cases of familial
arrhythmogenic cardiomyopathy (ACM). Recent studies show that PKP2 not only maintains
intercellular coupling, but also regulates transcription of genes involved in Ca2+ cycling and cardiac
rhythm. ACM penetrance is low and it remains uncertain, which genetic and environmental modifiers
are crucial for developing the cardiomyopathy. In this study, heterozygous PKP2 knock-out mice
(PKP2-Hz) were used to investigate the influence of exercise, pressure overload, and inflammation on
a PKP2-related disease progression. In PKP2-Hz mice, protein levels of Ca2+-handling proteins were
reduced compared to wildtype (WT). PKP2-Hz hearts exposed to voluntary exercise training showed
right ventricular lateral connexin43 expression, right ventricular conduction slowing, and a higher
susceptibility towards arrhythmias. Pressure overload increased levels of fibrosis in PKP2-Hz hearts,
without affecting the susceptibility towards arrhythmias. Experimental autoimmune myocarditis
caused more severe subepicardial fibrosis, cell death, and inflammatory infiltrates in PKP2-Hz
hearts than in WT. To conclude, PKP2 haploinsufficiency in the murine heart modulates the cardiac
response to environmental modifiers via different mechanisms. Exercise upon PKP2 deficiency
induces a pro-arrhythmic cardiac remodeling, likely based on impaired Ca2+ cycling and electrical
conduction, versus structural remodeling. Pathophysiological stimuli mainly exaggerate the fibrotic
and inflammatory response.
Keywords: arrhythmogenic cardiomyopathy; plakophilin-2; second hit; calcium handling; fibrosis;
exercise; cardiac pressure overload; inflammation
1. Introduction
Arrhythmogenic right ventricular cardiomyopathy (ACM) is an inherited heart disease
characterized by fibrous or fibrofatty infiltration of the cardiac muscle, ventricular arrhythmias,
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and increased propensity for sudden death. Sudden cardiac arrest most often occurs in early adulthood
during the subclinical (or “concealed”) phase of the disease, when overt cardiomyopathy is not yet
detectable by imaging, and is the first disease manifestation in a high proportion of probands [1–3].
ACM associates primarily with variations in genes coding for desmosomal proteins. One of the most
commonly mutated genes in ACM is PKP2, which encodes the desmosomal protein plakophilin-2
(PKP2) [4,5]. Genetic variants are transmitted autosomal dominantly and prevalence of symptom onset
varies [6]. Penetrance of the disease is low and it remains unknown which genetic and environmental
modifiers are required for development of the cardiomyopathy. Understanding cardiac remodeling
upon environmental stress factors is therefore paramount to understand the mechanisms underlying
sudden death and deterioration of cardiac performance.
PKP2 was first described as a component of the desmosome, a cellular structure involved in
cell–cell adhesion [7]. Desmosomal dysfunction results in intercellular gap widening and apoptosis of
the cardiomyocytes [8,9]. As a result, cardiac progenitor cells and cardiac myocytes may differentiate
into fatty or fibrous tissue, proceeding into fibrous and fatty infiltrates that disrupt normal cardiac
electrical impulse propagation [10]. Recent studies show that the intercalated disk (ID; including PKP2)
not only maintains intercellular coupling, but also modulates transcription pathways fundamental
for intracellular Ca2+ cycling and cardiac rhythm [5,11]. PKP2 variants lead to phenotypes that vary
from purely arrhythmogenic to severe mechanical dysfunction and therefore pkp2 alterations are also
linked to inherited cardiac conditions as Brugada syndrome and Catecholaminergic polymorphic
ventricular tachycardia (CPVT) [12–14]. Total knockout of Pkp2 in mice is embryonically lethal,
although heterozygous PKP2 deletion in mice does not induce clear phenotypical manifestations and
mice live through adulthood. Expression levels and localization of desmosomal proteins (other than
PKP2), adherens junction protein, and gap junctional protein are not changed in PKP2 haploinsufficient
(PKP2-Hz) mice [15]. Ultrastructural analysis however revealed an increased average intercellular
spacing and reduced number and length of mechanical junctions in PKP2-Hz mice [16]. In addition,
PKP2-Hz mice present a reduced peak sodium current density and a negative shift of INa steady-state
inactivation, which remains masked without addition of sodium channel blockers. Provocation with
the sodium channel blocker flecainide in PKP2-Hz animals impairs ventricular conduction, triggers
ventricular arrhythmias, and predisposes to sudden death [15].
Additional to PKP2 variants, several additional factors (secondary hits) have been proposed
to contribute to ACM development. Participation in endurance exercise is a key risk factor for
developing ACM, its progression toward heart failure, and for the occurrence of arrhythmias and
sudden death [17–19]. In that regard, patients with ACM are often recommended to avoid endurance
training [20]. To date, the involvement of cardiac pressure overload in developing ACM is not well
studied yet. Left ventricular hypertrophy induced by cardiac pressure overload is a known precursor
of heart failure with severe prognosis [21]. Pressure overload in combination with a loss of desmosomal
integrity elevates mechanical stress in cardiac tissue, disturbs intracellular homeostasis, and activates
stress-related pathways [5]. Inflammation is a common finding in ACM, the inflammatory response can
be caused by cell death, viral infection, or be a consequence of defective desmosomes [22–24]. Genetic
variants underlying ACM can induce immune alterations that make the heart more vulnerable for
myocarditis [25,26]. Separate studies have revealed elevated levels of serum inflammatory mediators
and myocardial expression of IL-17 and TNF-alpha in patients with ACM [23]. As well, acute
myocarditis reflects an active phase of ACM and accelerates ACM [27]. Conversely, the genetic
background can influence the susceptibility towards this superimposed myocarditis [27].
Here, we examined the influence of exercise, cardiac pressure overload, and autoimmune
myocarditis on the progression of ACM using a mouse model of PKP2 haploinsufficiency. Hearts of
PKP2-Hz mice showed a reduced expression of Ca2+-handling-related proteins, confirming intracellular
Ca2+ disturbances as shown upon total loss of PKP2 expression [11]. Reduced expression of PKP2
exaggerated the (subepicardial) fibrotic and inflammatory response towards pathophysiologic stimuli
as pressure overload and inflammation. Exercise-induced pro-arrhythmic cardiac remodeling in
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PKP2-Hz hearts is likely based on impaired Ca2+ cycling and a disturbed electrical conduction,
instead of structural remodeling. Showing that PKP2 deficiency controls the cardiac response towards
environmental modifiers via different mechanisms.
2. Results
2.1. PKP2 Haploinsufficiency Impairs Expression of Calcium Handling-Related Proteins
In this study we used a heterozygous PKP2 knock-out (PKP2-Hz) mouse model, as described in
Cerrone et al. 2012 (Figure S1a) [15]. Since not all patients with a mutation in PKP2 show symptoms
of ACM, additional factors likely contribute to disease development. Such factors could be pressure
overload, exercise, and inflammation. We evaluated the potential contribution of several factors
to pathogenesis in PKP2-Hz mice (Figure S1b). The study of Cerrone et al. showed that levels of
intercalated disk proteins N-cadherin (Ncad), connexin 43 (Cx43), plakoglobin (PKG), and Nav1.5 are
normal in PKP2-Hz hearts, although the sodium current density and kinetics are affected [15]. Total
loss of PKP2 expression in mice modulated the transcription of genes important for Ca2+ handling and
cardiac rhythm, inducing cardiac arrhythmogenesis in the concealed stage of the disease [11]. In the
present study we first examined the protein levels of Ca2+-handling-related proteins via western blot
on ventricular lysates of three-month-old wildtype (WT) and PKP2-Hz mice (Figure 1). In PKP2-Hz
mice, ankyrinB (AnkB) expression was on average 27% reduced (p = 0.08), calsequestrin-2 (Casq2) 38%
(1.0 ± 0.06 vs. 0.62 ± 0.03; p ≤ 0.05), Cav1.2 22% (1.0 ± 0.068 vs. 0.78 ± 0.04; p ≤ 0.05) and SERCA2a
50% (p = 0.08; Figure 1). We confirmed these changes over the timespan of our intervention study. In
six-month-old PKP2-Hz mice AnkB was 24% reduced (1.0 ± 0.07 vs. 0.76 ± 0.08; p ≤ 0.05), SERCA2a
46% (p = 0.08) and Casq2 31%(1.0 ± 0.087 vs. 0.69 ± 0.04; p ≤ 0.05; Figure S2). Notably, impaired AnkB
expression has been recently associated with human ACM [28].
2.2. Characterization of PKP2-Hz Hearts Over Time
Since cardiac electrical and structural remodeling progresses with age, we compared three-month-
to six-month-old WT and PKP2-Hz murine hearts [29,30]. Histological analysis by hematoxylin and
eosin (H&E) and Picrosirius red revealed no structural modifications at both ages and genotypes
(Figure 2A,B), which was confirmed by RNA expression analysis of collagen- and inflammation-related
genes (Figure 2C). Timp2 expression was increased (0.83 ± 0.18 vs. 1.98 ± 0.40, p ≤ 0.05) in
three-month-old PKP2-Hz mice, but this effect did not persist over time (Figure 2C). The heart
weight/body weight (HW/BW) index decreased over time, but did not differ between WT and PKP2-Hz
mice (Figure 2D and Table S1). Electrophysiological parameters were unchanged and arrhythmia
incidence was rare in six-month-old WT hearts (10%; Figure 2E and Table S2). Western blot and
immunohistochemistry revealed no difference in expression and localization of Ncad and Cx43
(Figure 2F,G). PKG expression however was 49% lower in six-month-old PKP2-Hz hearts compared to
WT (1.0 ± 0.13 vs. 0.51 ± 0.03, p ≤ 0.05; Figure 2C).
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Figure 1. Remodeling of proteins involved in calcium signaling pathways in the PKP2-Hz mouse. 
Representative western blots (left) and average densitometry (right; n = 5 for all groups) of ankyrinB 
(AnkB), calsequestrin-2 (Casq2), Cav1.2, and SERCA2a, measured from wildtype and PKP2-Hz 
ventricular lysates of three-month-old mice. Left upper panels represent western blots, bottom panels 
according to ponceau staining used for quantification (mean ± SEM, * p < 0.05). 
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Since cardiac electrical and structural remodeling progresses with age, we compared three-
month- to six-month-old WT and PKP2-Hz murine hearts [29,30]. Histological analysis by 
hematoxylin and eosin (H&E) and Picrosirius red revealed no structural modifications at both ages 
and genotypes (Figure 2A,B), which was confirmed by RNA expression analysis of collagen- and 
inflammation-related genes (Figure 2C). Timp2 expression was increased (0.83 ± 0.18 vs. 1.98 ± 0.40, 
p ≤ 0.05) in three-month-old PKP2-Hz mice, but this effect did not persist over time (Figure 2C). The 
heart weight/body weight (HW/BW) index decreased over time, but did not differ between WT and 
PKP2-Hz mice (Figure 2D and Table S1). Electrophysiological parameters were unchanged and 
arrhythmia incidence was rare in six-month-old WT hearts (10%; Figure 2E and Table S2). Western 
Figure 1. Remodeling of proteins involved in calcium signaling pathways in the PKP2-Hz mouse.
Representative western blots (left) and average densitometry (right; n = 5 for all groups) of ankyrinB
(AnkB), calsequestrin-2 (Casq2), Cav1.2, and SERCA2a, measured from wildtype and PKP2-Hz
ventricular lysates of three-month-old mice. Left upper panels represent western blots, bottom panels
according to ponceau staining used for quantification (mean ± SEM, * p < 0.05).
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Figure 2. Absence of cardiac remodeling in three and six months old PKP2-Hz mice. (A) Hematoxylin 
and eosin staining of wildtype and PKP2-Hz heart sections, at three and six months of age; scale bar, 
100 µm. (B) Representative pictures of Picrosirius red staining (left panel) in the inner myocardium 
of wildtype and PKP2-Hz murine hearts of both ages; scale bar, 500 µm. Quantification of collagen 
abundance (right panel) in overview slides of whole heart sections (WT 3 months; n = 7, PKP2-Hz 
three months; n = 7, WT six months; n = 6, PKP2-Hz six months; n = 6, mean ± SEM). (C) Relative 
mRNA expression of Col1α1, Col1α2, MM9, Timp1, NF-κß, and IL-6 assessed by RT-qPCR in three 
(left) and six month old (right), wildtype and PKP2-Hz ventricular tissue (three months; n = 6 for all 
groups, six months; n = 4 for all groups, mean ± SEM, * p < 0.05). (D) Quantification of heart weight 
(HW) to body weight (BW) ratio (WT three months; n = 8, PKP2-Hz three months; n = 8, WT six 
months; n = 10, PKP2-Hz six months; n = 10, mean ± SEM, * p < 0.05). (E) Percentage of Langendorf-
perfused hearts within each group susceptible for sustained ventricular arrhythmias by epicardial 
Figure 2. Absence of cardi c remodeling in three a si onths old KP2-Hz mice. (A) Hematoxylin
and eosi staining of wildtype and PKP2-Hz hea ctions, at three and six months of ge; scale bar,
100 µm. (B) Representative pictures of Picrosirius red staining (left panel) in the inner myocardium
of wildtype and PKP2-Hz murine hearts of both ages; scale bar, 500 µm. Quantification of collagen
abundance (right panel) in overview slides of whole heart sections (WT 3 months; n = 7, PKP2-Hz three
months; n = 7, WT six months; n = 6, PKP2-Hz six months; n = 6, mean ± SEM). (C) Relative mRNA
expression of Col1α1, Col1α2, MM9, Timp1, NF-κß, and IL-6 assessed by RT-qPCR in three (left) and
six month old (right), wildtype and PKP2-Hz ventricular tissue (three mon hs; n = 6 for all groups,
six months; n = 4 for all groups, mean ± SEM, * p < 0.05). (D) Quantificati of heart weight (HW)
to body weight (BW) ratio (WT three months; n = 8, PKP2-Hz three months; n = 8, WT six months;
n = 10, PKP2-Hz six months; n = 10, mean ± SEM, * p < 0.05). (E) Percentage of Langendorf-perfused
hearts within each group susceptible for sustained ventricular arrhythmias by epicardial pacing (WT
three months; n = 8, PKP2-Hz three months; n = 8, WT six months; n = 10, PKP2-Hz six months;
n = 10). (F) Representative western blots (bottom) and average densitometry of N-cadherin (Ncad),
connexin 43 (Cx43), and plakoglobin (PKG; top, WT; n = 6, PKP2-Hz n = 5 for Cx43 and PKG, WT;
n = 4, PKP2-Hz n = 5 for Ncad), measured from wildtype and PKP2-Hz ventricular lysates, six months
of age. Upper panels represent western blots, bottom panels according ponceau staining used for
quantification (mean ± SEM, * p < 0.05). (G) Immunofluorescence staining for Cx43 (green) and Ncad
(red) in wildtype (WT) and PKP2-Hz (PKP2) heart sections of three (3M) and six months (6M) of age;
Scale bar, 100 µm.
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2.3. Pro-Arrhythmic Cardiac Remodeling in PKP2-Hz Mice Exposed to Exercise
As endurance training decreases cardiac function and provokes ventricular arrhythmias [17,18],
PKP2-Hz mice were subjected to one-month voluntary running on a treadmill. PKP2-Hz mice exposed
to exercise training did not show increased levels of fibrosis (Figure 3A, Figure S3), signs of hypertrophy
(Figure 3B,C, Table S1), affected cardiac contractility (Figure 3F), or changes in electrocardiogram (ECG)
parameters (Table S2), compared to controls. The arrhythmia incidence was clearly higher in trained
PKP2-Hz mice compared to trained WT animals (PKP2-Hz vs. WT; 40% vs. 0%; Figure 3H). Impaired
intracellular Ca2+ dynamics (as shown in the three- and six-month-old mice) in combination with
endurance exercise possibly increases the susceptibility towards arrhythmias in PKP2-Hz hearts [11].
To confirm our previous findings in three- and six-month-old mice, we examined Ca2+
handling-related protein levels in ventricular lysates of WT and PKP2-Hz hearts exposed to exercise
training. In PKP2-Hz hearts the expression of AnkB, Casq2, and Cav1.2 was significantly lower than
in WT hearts (AnkB 49%: 1.0 ± 0.14 vs. 0.51 ± 0.066, p ≤ 0.05; Cav1.2 37%: 1.0 ± 0.08 vs. 0.63 ± 0.097,
p ≤ 0.05; and Casq2 49%: 1.0 ± 0.08 vs. 0.51 ± 0.02, p ≤ 0.05; Figure 3D). We then investigated proteins
involved in myocardial cell–cell coupling. Cx43 expression was consistent between WT and PKP2-Hz
hearts exposed to exercise training, whereas levels of Ncad and PKG seemed lower in PKP2-Hz hearts
than in WT (Ncad; 1.0 ± 0.15 vs. 0.67 ± 0.04, p ≤ 0.05, and PKG; 1.0 ± 0.17 vs. 0.58 ± 0.08, p = 0.08;
Figure S4). Impaired Ncad and PKG expression implicates disturbed mechanical coupling between
cardiomyocytes in PKP2-Hz hearts that could affect electrical signaling between cells.
To study the electrical cell–cell coupling in trained mice we analyzed Cx43 localization by
immunofluorescence and measured the ventricular conduction velocity by epicardial mapping.
PKP2-Hz mice exposed to voluntary exercise presented right ventricular lateral Cx43 expression
(Figure 3E) and longitudinal right ventricular conduction slowing, compared to WT mice
(left ventricle—LV: 72.10 ± 9.97 vs. 67.43 ± 1.94, ns.; and right ventricle—RV: 59.98 ± 2.58 vs.
52.78 ± 6.11, p < 0.05; Figure 3G). The transversal ventricular conduction velocity did not differ between
groups (Figure 3G).
2.4. Cardiac Pressure Overload is Pro-Fibrotic in the PKP2 Happloinsufficient Heart
Trans aortic constriction (TAC) surgery induces extensive electrical and structural remodeling of
the heart and increases arrhythmia vulnerability [31]. To study if pressure overload in combination with
loss of PKP2 expression excaggarates the disease progression, we performed TAC surgery on PKP2-Hz
and WT mice. Eight weeks after TAC surgery, in both groups hypertrophy was observed (HW/BW
WT-Sham: 5.95 ± 0.26 mg/g; WT-TAC: 8.60 ± 1.99 mg/g, p ≤ 0.05; PKP2-Hz Sham: 5.84 ± 0.92 mg/g;
and 8.44 ± 1.85 mg/g; p ≤ 0.01), fractional shortening was reduced (WT-Sham: 48.54% ± 1.2%; WT-TAC:
37.43% ± 3.0%, p ≤ 0.0001; PKP2-Hz Sham: 47.3% ± 2.9%; and PKP2-Hz TAC 37.34% ± 5.5%, p ≤ 0.001)
and QRS duration prolonged (WT-Sham: 9.18 ± 0.5 ms; WT-TAC: 11.01 ± 0.9 ms, p ≤ 0.05; PKP2-Hz
Sham: 8.69 ± 0.4 ms, and PKP2-Hz TAC: 11.51 ± 0.6 ms, p ≤ 0.05). These aspects of cardiac remodeling
however did not differ between WT and PKP2-Hz mice (Figure 4A–D, Tables S2 and S3). Ventricular
repolarization (QTc) was similar between groups (Figure 4D). The susceptibility to sustained ventricular
arrhythmias mildly increased due to TAC surgery, with only slightly higher levels in PKP2-Hz TAC
than in WT TAC mice (WT TAC vs. PKP2-Hz TAC; 10% vs. 20%; Figure 4E).
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Representative western blots (left panel) and average densitometry (right panels, n = 5 for all groups) 
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sections, of mice exposed to exercise; scale bar, 100 µm. (C) Quantification of heart weight (HW) to body
weight (BW) ratio in both groups (WT; n = 5 and PKP2-Hz; n = 5, mean ± SEM). (D) Representative
western blots (left panel) and average densitometry (right panels, n = 5 for all groups) of AnkyrinB
(ANKB), Cav1.2, and calsequestrin-2 (Casq2) measured from wildtype (WT) and PKP2-Hz ventricular
lysates of mice exposed to exercise training. Left upper panels represent western blots, bottom panels
according ponceau staining used for quantification (mean ± SEM, * p < 0.05). (E) Immunofluorescence
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staining for Cx43 (red) and Ncad (green) in right ventricular heart sections of WT and PKP2-Hz mice;
scale bar, 100 µm. Upper right panel shows magnified shots of according merged pictures, indicated
by the white boxes. Lateral Cx43 expression is more pronounced in PKP2-Hz hearts exposed to
exercise training, indicated by white arrows. (F) Left ventricular fractional shortening examined via
echocardiography in hearts of wildtype (WT) and PKP2-Hz mice after one-month of training (WT; n = 5
and PKP2-Hz; n = 5, mean ± SEM). (G) Conduction (CV) velocity measured by epicardial mapping on
the left ventricle (LV) and right ventricle (RV) in longitudinal (left) and transverse (right) directions in
hearts of wildtype (WT) and PKP2-Hz mice (WT; n = 5 and PKP2-Hz; n = 5, mean ± SEM, * p < 0.05).
(H) Percentage of Langendorf-perfused hearts, within each group, susceptible for sustained ventricular
arrhythmias by epicardial pacing (WT; n = 5 and PKP2-Hz; n = 5).
To further investigate the determinants of arrhythmogenicity in these mice, we performed tissue
analyses for expression of cell-coupling proteins and interstitial fibrosis. Immunolabelling revealed
no difference in expression and localization of NCad and Cx43 (Figure 4F). Sirius red staining for
collagen abundance presented significant higher levels of interstitial (but not subepicardial) fibrosis in
PKP2-Hz TAC mice compared with sham-treated WT and PKP2-Hz mice (WT-Sham: 1.64% ± 0.1%;
WT-TAC 2.83% ± 0.95%; PKP2-Hz Sham: 1.86% ± 0.29%; and PKP2-Hz TAC: 5.0% ± 0.86%, p ≤ 0.05 vs.
WT-Sham and PKP2-Hz Sham; Figure 4G,H). To explore if the Wnt signalling pathway was involved in
this pro-fibrotic response, we examined protein levels of β-catenin in ventricular lysates of all groups.
Levels of β-catenin were significantly higher in ventricular lysates of TAC mice and this difference was
more pronounced in PKP2-Hz mice compared to WT (Figure S5).
2.5. PKP2 Haploinsufficiency Alters the Cardiac Fibrotic and Inflammatory Response to
Auto-Immune Myocarditis
Inflammation, in the form of a viral infection or acute inflammatory response, has been suggested
to trigger arrhtyhmogenic cardiomyopathy [23]. To investigate whether inflammation indeed affects
disease progression upon loss of PKP2 expression, we induced experimental autoimmune myocarditis
(EAM) in PKP2-Hz and WT mice. Cardiac structural remodeling was studied after three weeks (innate
immune response) and six weeks (chronic immune response) of EAM onset. Picrosirius red staining
revealed no difference in the collagen content of whole-heart sections, neither after three nor six weeks of
EAM (Figure 5A,B). Three weeks after EAM, PKP2-Hz hearts tended to have more subepicardial fibrosis,
while after six weeks, this difference was significant (WT six weeks: 6.24% ± 1.6%; and PKP2-Hz six
weeks: 14.16% ± 3.3%, p ≤ 0.05; Figure 5A,B). By determining the ratio of damaged area to total tissue,
more subepicardial damage was found in PKP2-Hz compared to WT mice, three and six weeks after
EAM induction, and most pronounced after six weeks (three weeks WT: 5.04% ± 1.4%; three weeks
PKP2-Hz: 10.17% ± 2.0%; six weeks WT: 6.02% ± 1.1%; six weeks PKP2-Hz 20.16% ± 3.8%, p ≤ 0.05 vs.
three weeks PKP2-hz and p ≤ 0.001 vs. six weeks WT; WT untreated: 1.34% ± 0.5%, p ≤ 0.05 vs. six
weeks WT; and PKP2-Hz untreated: 2.76% ± 1.5%, p ≤ 0.05 vs. six weeks PKP2-Hz; Figure 5C,D). These
observations corresponded to the findings in Cx43 and vimentin-myosin staining of three and six week
EAM hearts. PKP2-Hz mice showed a loss of Cx43 expression and larger non-myocyte areas than WTs,
three and six weeks after EAM induction (three weeks WT: 0.08% ± 0.02%; PKP2-Hz: 0.18% ± 0.02%,
p ≤ 0.01, six weeks WT: 0.12% ± 0.03%; and PKP2-Hz: 0.23% ± 0.05%, p ≤ 0.05; Figure 5E,F). On top of
that, in the 0.2 mm subepicardial layer, PKP2-Hz mice showed a higher neutrophil-positive area than
WT mice three weeks pro-EAM onset (Figure 5G). No neutrophils were present in the six-weeks group
(data not shown) because the initial immune response most likely had subsided at that timepoint. This
subepicardial response of the PKP2-Hz heart towards inflammation did not cause alterations in cardiac
contractility or ECG parameters (Figure S6 and Table S2).
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Hz sham; n = 8, WT TAC; n = 8, and PKP2-Hz TAC; n = 9, mean ± SEM, *** p < 0.001). (D) QRS duration 
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5, PKP2-Hz sham; n = 8, WT TAC; n = 8, and PKP2-Hz TAC; n = 9, mean ± SEM, *** p < 0.001). (E) 
Percentage of Langendorf-perfused hearts, within each group, susceptible for sustained ventricular 
arrhythmias by epicardial pacing (WT Sham; n = 5, PKP2-Hz sham; n = 8, WT TAC; n = 8, and PKP2-
Hz TAC; n = 9). (F) Immunofluorescence staining for Cx43 (green) and Ncad (red) in wildtype and 
PKP2-Hz (PKP2) heart sections of mice exposed to Sham (SH) or TAC surgery; scale bar, 100 µm. (G) 
Representative pictures of Picrosirius red staining (left panel) in the inner myocardium of all four 
groups; scale bar, 500 µm. Quantification of collagen abundance (right panel) in overview slides of 
whole heart sections (WT Sham; n = 5, PKP2-Hz sham; n = 8, WT TAC; n = 8, and PKP2-Hz TAC; n = 
9, mean ± SEM, * p < 0.05). (H) Quantification of collagen abundance (right panel) in the 0.2 mm 
subepicardial layer, examined in overview slides of whole heart sections (WT Sham; n = 5, PKP2-Hz 
sham; n = 8, WT TAC; n = 8, and PKP2-Hz TAC; n = 9, mean ± SEM). 
Figure 4. Pro-fibrotic cardiac remodeling in PKP2-Hz trans aortic constriction (TAC) operated mice.
(A) Hematoxylin and eosin staining of wildtype and PKP2-Hz heart sections of Sham and TAC operated
mice; scale bar, 100 µm. (B) Quantification of heart weight (HW) to body weight (BW) ratio in all
four groups (WT Sham; n = 5, PKP2-Hz sham; n = 8, WT TAC; n = 8, and PKP2-Hz TAC; n = 9,
mean ± SEM, ** p < 0.01). (C) Left ventricular fractional shortening examined by echocardiography
in wildtype (WT) and PKP2-Hz mice after eight weeks of TAC/Sham surgery (WT Sham; n = 5,
PKP2-Hz sham; = 8, WT TAC; n = 8, and PKP2-Hz TAC; n = 9, mean ± SEM, *** p < 0.001). (D) QRS
duration (left) and ventricu ar repolarization (QT) ti e corrected for heart rate (QTc; rig t) examined
via electrocardiogra s in wildtype (WT) and PKP2-Hz mice after eight weeks of surgery (WT Sham;
n = 5, PKP2-Hz sham; n = 8, WT TAC; n = 8, and PKP2-Hz TAC; n = 9, mean ± SEM, *** p < 0.001).
(E) Percentage of Langendorf-perfused hearts, within each group, susceptible for sustained ventricular
arrhythmias by epicardial pacing (WT Sham; n = 5, PKP2-Hz sham; n = 8, WT TAC; n = 8, and
PKP2-Hz TAC; n = 9). (F) Immunofluorescence staining for Cx43 (green) and Ncad (red) in wildtype
and PKP2-Hz (PKP2) heart sections of mice exposed to Sham (SH) or TAC surgery; scale bar, 100 µm.
(G) Representative pictures of Picrosirius red staining (left panel) in the inner myocardium of all four
groups; scale bar, 500 µm. Quantification of collagen abundance (right panel) in overview slides of
whole heart sections (WT Sham; n = 5, PKP2-Hz sham; n = 8, WT TAC; n = 8, a d PKP2-Hz TAC;
n = 9, mean ± SEM, * p < 0.05). (H) Quantificatio of coll gen abundance (right panel) in the 0.2 mm
subepicardial layer, examined in overview slides of whole heart sections (WT Sham; n = 5, PKP2-Hz
sham; n = 8, WT TAC; n = 8, and PKP2-Hz TAC; n = 9, mean ± SEM).
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Figure 5. Exaggerated cardiac fibrotic and inflammatory response in PKP2-Hz mice exposed to
autoimmune myocarditis. (A) Representative pictures of Picrosirius red staining (left panel) of the
outer myocardial layer in wildtype and PKP2-Hz murine heart sections, of mice after three weeks
of experimental auto-immune myocarditis (3wk EAM) and six weeks of experimental auto-immune
myocarditis onset (6wk EAM; scale bar, 750 µm). (B) Quantification of collagen abundance in the entire
heart (left panel) and 0.2 mm subepicardial region (right panel) of wildtype (WT) and PKP2-Hz (PKP2)
mice after three weeks experimental autoimmune myocarditis (EAM) and six weeks EAM onset or
without treatment (untreated; WT 3wk EAM; n = 9, PKP2 3wk EAM, n = 11, WT 6wk EAM; n = 16,
PKP2 3wk EAM, n = 15, WT untreated; n = 5, and PKP2 untreated, n = 4, mean ± SEM, * p < 0.05).
(C) Hematoxylin and eosin (H&E) staining in wildtype and PKP2-Hz heart sections exposed to EAM;
scale bar, 500 µm. (D) Quantification of damaged area in the 0.2 mm subepicardial layer of wildtype
(WT) and PKP2-Hz (PKP2) mice hearts exposed to EAM or without any treatment, quantification was
performed on H&E stained heart sections (WT 3wk EAM; n = 9, PKP2 3wk EAM, n = 11, WT 6wk
EAM; n = 16, PKP2 6wk EAM, n = 15, WT untreated; n = 5, and PKP2 untreated, n = 4, mean ± SEM,
* p < 0.05, *** p < 0.001). (E) Representative examples of Connexin 43 (Cx43) immunohistochemistry
labeling in the subepicardial region of WT and PKP2-Hz heart sections exposed to EAM; scale bar,
100 µm. (F) Representative examples (right) of myosin (red) and vimentin (green) immunofluorescence
labeling and quantification of non-myosin area (left) in wildtype and PKP2-Hz heart sections of mice
exposed to EAM; scale bar, 100 µm. The non-myosin area was examined in the epicardial layer of both
ventricles, areas were normalized by the length of the epicardium (WT 3wk EAM; n = 8, PKP2 3wk
EAM, n = 11, WT 6wk EAM; n = 16, and PKP2 6wk EAM, n = 15, mean ± SEM, * p < 0.05, ** p < 0.01).
(G) Quantification of Ly6C/6G (neutrophil) coverage area (left) in whole heart and 0.2 mm subepicardial
regions of wildtype and PKP2-Hz mice after three weeks EAM onset (WT whole heart; n = 8, PKP2
whole heart, n = 11, WT subepicard; n = 9, and PKP2 subepicard, n = 11, mean ± SEM, * p < 0.05).
Representative example (right) of the neutrophil positive area in both groups; scale bar, 500 µm.
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3. Discussion
ACM is seen as a disease of the intercalated disc (ID) and human variants in PKP2 associate
with most familial ACM cases. PKP2 is mainly a component of the desmosome, a cellular structure
involved in cell–cell adhesion [5,11,32]. Besides PKP2, genetic variants in other desmosomal genes
(Desmocollin2; DSC2, Desmoglein2; DSG2, and Plakoglobin; PKG), have been linked to ACM as
well [33]. Since the environmental and genetic modifiers of ACM remain unknown, we examined the
effect of exercise, cardiac pressure overload, and inflammation on the progression of a PKP2-related
cardiomyopathy. We show that PKP2 deficiency modulated the cardiac response to environmental
modifiers via different mechanisms. Exercise induced a pro-arrhythmic cardiac remodeling, likely
based on a combination of impaired Ca2+ cycling and electrical conduction. Upon pathophysiological
stimuli, PKP2 haploinsufficiency mainly exaggerated the fibrotic and inflammatory response.
First of all, we found that PKP2 haploinsufficient mice displayed deficits in Ca2+-handling-related
proteins, most critically of CaV1.2, SERCA2a, AnkB, and Casq2. This correlates with findings in PKP2
conditional global knock-out (PKP2cKO) mice, in which the expression of proteins involved in Ca2+i
cycling is markedly reduced [11]. Altered Ca2+i transients and Cx43 disfunction potentially causes
the ventricular arrhythmias in these mice [11,34]. In addition, PKP2cKO mice present biventricular
mechanical dysfunction and fibrosis formation, both starting in the right ventricle [11]. Spontaneous
ventricular arrhythmias were observed before the onset of LV dysfunction, followed by end-stage
failure and sudden death [11]. In contrast, PKP2-Hz hearts did not display arrhythmogenic events,
suggesting that a 50% reduction of PKP2 did not suffice to provoke spontaneous ectopic activity in
the heart. It is tempting to speculate that a combination of factors was needed to induce pathological
(electrical) remodeling upon PKP2 deficiency. In humans, PKP2 variants are transmitted in an
autosomal-dominant manner and mutation carriers can proceed throughout life without developing
any signs of cardiomyopathy, similar as observed in the PKP2-Hz mouse model [6,15,35].
In mice, heterozygous loss of PKP2 expression associates with ultrastructural defects, sodium
current deficits and hampered sodium channel inactivation kinetics [15,16]. However, under baseline
conditions PKP2-Hz mice appear farily nomal and lack an overt disease phenotype [15]. In line with
the literature, three- or six-month-old PKP2-Hz mice displayed no structural or electrical abnormalities.
This might be explained by the relatively young age of the mice. We acknowledged that six months
of age is still mild ageing in mice and increasing the age towards 18–22 months would probably
enhance fibrosis formation and arrhythmia incidence [36]. Senescent mice become arrhythmogenic by
increased interstitial fibrosis levels and redistributed Cx43 [36]. However, whether extensive aging
will discriminate between WT and PKP2-Hz mice remains to be determined.
In line with the literature we observed that PKP2-Hz hearts of mice exposed to one month
of voluntary running displayed a higher vulnerability towards sustained ventricular arrhythmias,
although lacking any signs of fibrosis [9,12]. While in humans ACM penetrance is low, exercise
also greatly increases the risk for developing the cardiomyopathy and for its progression toward
failure [17,19]. Life-threatening ventricular arrhythmias or sudden death often occur in the concealed
phase of the disease, prior to overt structural damage [37]. The underlying mechanisms responsible
for these arrhythmias remain under study but a disturbed electrical coupling could be an important
factor [15]. Acute adrenergic stimulation of PKP2 null mice associates with malignant ventricular
arrhythmias and sudden death, mimicking exercise during the concealed phase of the disease [11].
In accordance, exercise training in PKP2-R735 mutant mice appeared crucial for developing the ACM
phenotype [18]. In addition, we show that a 50% reduction of PKP2 expression was not associated
with exercise-induced contractile impairment, in contrast to the study of Cruz et al. [18]. Important
to note is the difference in the PKP2 model (PKP2-Hz vs. AAV-induced PKP2-R735 mice), the
extent of exercise training (one month of running vs. eight weeks of swimming), and the contractile
parameters examined (left ventricular fractional shortening (LVFS) vs. right ventricular ejection fraction
(RVEF)) [18]. For future studies, we recommend to explore RV contractility in PKP2-Hz mice exposed
to exercise training. Sudden death upon exercise was not observed, and PKP2-Hz mice and their hearts
Int. J. Mol. Sci. 2019, 20, 4076 12 of 21
lack any signs of hypertrophy. However, we could not control the intensity of training in our voluntary
exercise experiments. Chronic isoproterenol infusion in PKP2-Hz mice would allow studying the effect
of adrenergic stimulation on disease development in a more controlled experimental setting [38].
Exercise training of PKP2-Hz mice associates with RV conduction slowing, potentially caused by a
combination of impaired mechanical coupling, reduced peak sodium current and redistributed
Cx43 [15,18,36]. The absence of structural remodeling in our PKP2-Hz mice suggests that
exercise-induced pro-arrhythmic remodeling in PKP2-Hz hearts is caused by an impaired cardiac
electrical conduction. The reduced expression of Ca2+-handling-related proteins in trained PKP2-Hz
hearts is likely not pro-arrhythmic in itself. Though it is tempting to speculate that a combination
of impaired intracellular Ca2+ cycling and impaired intercellular electrical coupling serves as a
pro-arrhythmic substrate in exercise-exposed PKP2-Hz hearts. This needs to be confirmed by in vivo
recordings of ventricular arrhythmias in PKP2-Hz mice during exercise, for example by telemetry.
Cardiac pressure overload is a well-known contributor to electrical and structural remodeling
of the heart and a risk factor for cardiac arrhythmias [39,40]. In line with the literature we observed
that TAC surgery induced hypertrophy, impaired cardiac contractility, and increased susceptibility
for arrhythmias; however, PKP2-Hz mice presented similar effects as WT mice [21,39]. TAC surgery
increased collagen abundance predominantly in PKP2-Hz hearts. This implicates that PKP2 is involved
in regulating the cardiac fibrotic response, as PKP2 haploinsufficiency might lead to activation of
pro-fibrotic pathways, inflammation, and apoptosis [40,41]. Enhanced ß-catenin levels in PKP2-Hz
TAC mice might confirm this hypothesis, since a loss of desmosomal integrity alters the Wnt-signalling
pathway, a well-known contributor to adipo-and fibrogenensis and ACM pathology [42]. Imbalance of
the intracellular Ca2+ homeostasis and hypertrophic signals possibly increase calcineurin activation in
the heart and subsequent inflammatory-driven fibrosis in PKP2-Hz TAC mice [43]. Additional studies
are needed to confirm these hypotheses.
In this study we exposed PKP2-Hz mice to an experimental auto-immune myocarditis and
studied the acute and innate immune response of the heart. Whole heart collagen levels were not
affected by the intervention, although PKP2-Hz mice developed severe levels of subepicardial fibrosis
and myocardial damage six weeks after EAM onset. Inflammation was a common finding in ACM.
The inflammatory response could be caused by cell death, viral infection, or be a consequence of defective
desmosomes [44,45]. Endomyocardial biopsies of ACM patients show features of myocarditis-like
inflammation or fibrofatty replacement, possibly reflecting different stages of the disease [27,46].
Acute myocarditis reflects an active phase of ACM and is a superimposed phenomenon during the
natural history of the disease [27]. Cardiac fibrofatty replacement in desmosomal mutation carriers is
mainly located in the posterolateral wall of the heart, confirming the observations we saw in PKP2-Hz
mice exposed to EAM [47]. The molecular mechanism underlying this epicardial response is still
under debate. Paracrine signaling between PKP2-positive and PKP2-negative cells in the epicardial
region of PKP2-Hz mice is a likely causative factor, activating a TGF-β1/p38 MAPK-dependent fibrotic
gene expression [48]. Inflammatory infiltrates were already present at three weeks post-EAM onset
in PKP2-Hz mice, suggesting an inflammation-driven fibrotic response. We concluded that PKP2
deficiency altered the cardiac inflammatory and fibrotic response to EAM. This study fitted the
hypothesis that ACM might be triggered by infection, as desmosomal mutations compromised the
resilience of the heart to inflammation. Inflammation itself may also be arrhythmogenic as previous
data suggest that cytokines can alter sodium current function [49]. Future studies are needed to unravel
the exact arrhythmic potential of EAM in the PKP2 haploinsufficient heart.
In conclusion, reduced expression of PKP2 in the murine heart affects Ca2+-cycling-related
protein levels and modulates the cardiac reponse towards environmental modifiers. Cardiac pressure
overload and auto-immune myocarditis drive (subepicardial) pro-fibrotic mechanisms in the PKP2
happloinsufficient heart. Exercise-induced pro-arrhythmic cardiac remodeling in hearts with reduced
expression of PKP2 is based upon impaired electrical conduction instead of structural remodeling. Our
data presented potential important disease mechanisms in a PKP2-related cardiomyopathy.
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4. Study Limitations
The data presented in this study suggest that decreased levels of Ca2+-handling proteins played a
maladaptive role in the development of different cardiac phenotypes upon environmantal modifiers in
PKP2-Hz mice. Levels of Ca2+-handling-related proteins were not examined in mice exposed to cardiac
pressure overload and autoimmune myocarditis, so whether cardiac remodeling and Ca2+-handling
disturbances were directly linked in these models remains uncertain. In addition, no intracellular Ca2+
measurements were executed. More in-depth in vitro studies need to be performed to confirm the
definite effect of PKP2 haploinsuffiency on cardiac Ca2+ dynamics. Another limitation of this study
was the lack of arrhythmia score in PKP2-Hz hearts exposed to autoimmunce myocarditis. Histological
examination showed that pathophysiological stimuli mainly exacerbated the fibrotic and inflammatory
response, but pro-arrhythmic remodeling in PKP2-Hz hearts exposed to autoimmune myocardits
could not be excluded
5. Materials and Methods
5.1. Mouse Model
Mice heterozygous-null for the PKP2 gene (PKP2-Hz) was generated and genotyped as described
previously [7]. Except where noted, experiments were conducted in PKP2-Hz and WT littermate
C57BL/6J mice (Charles River, Lyon, France) of both genders. For the EAM studies, mice were
backcrossed onto the BALB/c background. Animal experiments were performed according to
institutional guidelines, the Dutch Experiments on Animals Act and the New York University
and SUNY Upstate Medical University guidelines for animal use and care (2010.II.06.109 (04.10.2010),
2010.II.01.006 (09-02-2011), 2011.II.08.116 (15-10-2011), #177 (01-11-2009). Experiments were approved
by the local Animal Experiments Committees and conformed to the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of Health.
5.2. Transverse Aortic Constriction Procedure
Wildtype and PKP-Hz 12-week-old mice were TAC or sham operated as explained previously [50].
Briefly, mice were anesthetized by isoflurane (mean 2.5% in oxygen), intubated with a 20 G polyethylene
catheter, and ventilated (200 µL, 160 strokes/min) with a rodent ventilator (Minivent, Hugo Sachs
Electronics, March-Hugstetten, Germany). The thoracic cavity was accessed through a small incision
at the left upper sternal border in the second intercostal space. A 7-0 silk suture was passed around the
aorta between the right innominate and left common carotid arteries. Constriction of the transverse
aorta was performed by tying against a 27 G needle, which was subsequently removed. Sham-operated
mice underwent the same procedure without aortic binding. Eight weeks after surgery echocardiograms
and electrocardiograms were recorded, the mice were sacrificed by cervical dislocation and the hearts
were removed for histological studies.
5.3. Exercise Protocol
Wildtype and PKP2-Hz 12-week-old mice were housed solitary in a cage with a treadmill for one
month, where they were exposed to daily voluntary exercise training. After one-month voluntary
exercise training, echocardiograms and electrocardiograms were recorded, mice were sacrificed by
cervical dislocation and the hearts were removed for histological and electrophysiological studies.
5.4. Experimental Autoimmune Myocarditis
Myocarditis was induced by immunization with cardiac α-myosin heavy chain (AnaSpec Inc.,
Fremont, CA, USA) as explained previously [51]. 100 µg cardiac α-myosin heavy chain was dissolved
in 100 µL sterile phosphate buffered saline (PBS) and mixed with 100 µL of complete Freund’s adjuvant
(Sigma, F5881, st. Louis, MO, USA). This mixture was vortexed for 1.5 h to create an emulsion of
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antigen in complete Freund’s adjuvant. On day 0, 200 µL of emulsion was injected subcutaneously at
two flanks of wildtype and PKP2-Hz mice. For this study, mice were backcrossed onto the BALB/c
background as it is permissive for myocarditis [51]. In addition, the mice were injected intraperitoneally
with 500 ng of pertussis toxin (List Biological Laboratories, Campbell, CA, USA) dissolved in PBS.
The mice were monitored for at least one week following the injections. A mouse was euthanized if it
showed unusually large granulomas, ulcerations, or signs of being moribund. After three or six weeks,
echocardiograms and electrocardiograms were recorded, the mice were sacrificed by CO2 euthanasia
and the hearts were removed for histological studies.
5.5. Echocardiography
Transthoracic echocardiography was performed using a Vevo2100 Imaging System (VisualSonics
Inc., Toronto, Canada) with a 30 MHz probe. Briefly, after induction of anesthesia in a chamber
containing isoflurane 4%–5% in oxygen, the mouse was positioned supinely on a heat pad in order
to maintain a body temperature at 37–38 ◦C and anesthesia was maintained with 1.5% isoflurane in
700 mL O2/minute via a nose cone. Recordings were obtained in parasternal long and short axis views.
Quantitative measurements were assessed oﬄine using the Vevo2100 analytical software. A B-mode
parasternal long axis view was used for left ventricular ejection fraction. Left ventricular fractional
shortening was calculated from the parasternal short axis view (M-mode) [52].
5.6. Electrocardiograms Recordings
Mice were anesthetized with 1.5% isoflurane in 700 mL O2 per minute via a nose cone (following
induction in a chamber containing isoflurane 4%–5% in oxygen). The rectal temperature was monitored
continuously and maintained at 37–38 ◦C using a heat pad. Three lead ECG (leads I, II, and III)
were recorded from sterile needle electrodes inserted subcutaneously in each forelimb and hindlimb.
The signal was then acquired and analyzed using a digital acquisition and analysis system (Power
Lab; AD Instruments, Oxford, UK; LabChart 7Pro software version). ECG parameters were quantified
after 1–2 min from anesthesia induction, in order to stabilize the trace. The QT interval was defined as
the time elapsed from the beginning of the major deflection representing the QRS to the end of the
secondary slow deflection, as described by Danik et al. [53]. QT intervals were corrected for RR interval
by the equation (QTc = QT/(RR/100)1/2), according to Mitchell et al. [54]. Analysis was performed on
lead II electrocardiograms.
5.7. Epicardial Activation Mapping in Langendorf-Perfused Hearts
For epicardial activation mapping experiments, mice were anesthetized (4% isoflurane in oxygen)
and the hearts were quickly excised, rinsed, and placed on a Langendorf column for retrograde coronary
perfusion. Hearts were continuously perfused with a Tyrode solution containing: (in mmol/L): NaCl
116, KCL 5, MgSO4 1.1, NaH2PO4 0.35, NaHCO3 27, glucose 10, mannitol 16, and CaCl2 1.8 at 37 ◦C.
Solution was continuously gassed with 95% O2 and 5% CO2. Electrograms were recorded using a
247-point multiterminal electrode (19 × 13 mm grid, 0.3 mm spacing) placed over both the LV and
RV, as described before [36,50]. Recordings of the LV and RV were made during stimulation (2 ms
duration, 2× diastolic stimulation threshold) from the center of the grid at a basic cycle length (BCL)
of 120 ms. The moment of maximal negative dV/dt in the unipolar electrograms was selected as the
time of local activation and determined using customized software [55]. Conduction velocity parallel
(CVL) and perpendicular to fiber orientation were determined from activation maps generated from
BCL-pacing. Activation times of at least four consecutive electrode terminals along lines perpendicular
to intersecting isochronal lines were used to calculate CVs.
5.8. Western Blot Analysis
Total murine heart lysate was prepared as described previously [56]. Equal amounts of protein
(25µg/lane) of each sample were separated on 7% (for CaV1.2 and AnkyrinB) or 10% SDS-polyacrylamide
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gels (for the remaining proteins) and transferred by electrophoresis to nitrocellulose membranes (Bio-rad,
Veenendaan, Netherlands). Equal protein loading was assessed by Ponceau S staining. After the first
and second antibody incubation, immunoreactivity was detected using an ECL chemiluminescence kit
(Amersham, Piscataway, NJ, USA). The following antibodies were used for western blot: PKP2 (1:250;
Fitzgerald, 10R+P130b), plakoglobin (1:500; Sigma, P8087), Cx43 (1:250; Thermo scientific (Landsmeer,
Netherlands), 71-0700), N-cadherin (1:10000; Sigma, C12821), calsequestrin-2 (1:1000, Thermo scientific
(Landsmeer, Netherlands), PA1-913), ankyrinB (1:500, custom-made in Peter Mohler lab, city, OH,
USA), SERCA2a (1:1000, abcam (Camebridge, UK), Ab2861), CaV1.2 (1:500, alomone (Jerusalem, Israel),
ACC-003), and β-catenin (1:10000, BD transduction (Vianen, Netherlands), 610154). Secondary labeling
was performed with peroxidase-conjugated secondary antibodies (1:7000, Jackson ImmunoResearch,
Uden, Netherlands). Images for each western blot, and the corresponding Ponceau S staining, were
imported into ImageJ (2008, NIH, Bethesda, MD, USA). The density of each band in the Western
blot was normalized to the corresponding Ponceau S signal (after background subtraction) to correct
for loading.
5.9. PCR Validation of Gene Expression
Total RNA was extracted from the heart tissue of PKP2-Hz and control mice using an RNeasy
Mini Kit (QIAGEN, Hilden, Germany). The complement DNA (cDNA) was generated by reverse
transcription (RT)-PCR with SuperScript VILO cDNA Synthesis Kit (Thermo scientific, Landsmeer,
Netherlands). For RT-qPCR on ventricular tissue, TaqMan gene expression assays (all from Applied
Biosystems by Life Technologies Corp., Carlsbad, CA, USA) were used as described earlier [57].
As an internal control, the geometric mean of the TATA-binding protein (TBP) and glyceraldehyde
3-phosphate dehydrogenase (GAPDH) was used. Relative mRNA expression levels were determined
for collagen 1α1 (Col1α1), collagen 1α2 (Col1α2), metalloproteinase 9 (MMP9), metallopeptidase
inhibitor 1 (Timp1), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κß), and
interleukin-6 (IL-6). Assay IDs are listed in Table S3.
5.10. Immunofluorescence Labeling
For the detection of protein localization by immunofluorescence, hearts were rapidly frozen
in liquid nitrogen and stored at −80 ◦C. Hearts were sectioned (thickness: 10 µm) parallel to the
long axis of the heart. Sections displaying a four-chamber view were used for immunostaining
as previously described [56]. Samples were exposed to the primary antibodies Cx43 (1:250, BD
transduction, 610062), N-cadherin (1:1000, Sigma, C3678), chicken anti-vimentin (1:400, EMD Millipore
Corporation (Burlington, MA, USA), AB5733), and myosin (1:200, Enzo Life Sciences Inc. (Bruxelles,
Belgium), ALX-BC-1150-S-L001) for primary labeling. Afterwards, Cx43- and Ncad-labeled sections
were incubated with FITC conjugated anti-rabbit whole IgG or Texas Red-conjugated anti-mouse
whole IgG. Vimentin- and myosin-labeled sections were incubated with secondary antibodies Alexa
Fluor 488 goat anti-chicken IgG (1:500, abcam Inc., ab150169) and Alexa Fluor 568 goat anti-mouse
IgG (1:500, Thermo scientific (Landsmeer, Netherlands)), A-11031). After labeling, sections were
mounted in Vectashield (Vector Laboratories, Orton Southgate, Peterborough, UK) and visualized by
conventional epifluorescence and confocal microscopy (Nikon optiphot-2). To examine the non-myosin
area, pictures of 40 × magnification of the most damaged area in five heart areas; apex, left-ventricular
base/mid region, and right-ventricular base/mid region, were taken. The perimeter of empty area
continuous to the epicardial layer was manually selected (in triplet), excluding myocytes and vessels.
The non-myosin area continuous to the epicardium was normalized to the length of the epicardium.
5.11. Immunohistochemistry
For detection of inflammatory infiltrates and gap junctions by immunohistochemistry, hearts
were fixed with 4% paraformaldehyde in PBS. Hearts were sectioned (thickness: 10 µm) parallel
to the long axis of the heart. Labeling was performed using the ImmPRESS anti-rat Ig Reagent kit,
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peroxidase (Vector Laboratories Inc., MP-7444), and the ImmPACT NovaRED Peroxidase substrate kit
(Vector Laboratories Inc., SK-4805) to reduce background staining. Antigen retrieval was performed by
incubating the sections in a citrate buffer (Biogenex, HK-080-9K) and heating this for 25–30 min using a
steamer (Deni, Keystone Inc., Grand Island, NY, USA). Subsequently the sections were incubated with
0.5% hydrogen peroxide (Fisher Scientific (Landsmeer, Netherlands), H323-500) and incubated in 0.3%
normal goat serum (Sigma, G9023) in PBS. After blocking, the samples were incubated with primary
antibodies (Cx43, 1:250, Thermo Scientific 71-0700; anti-Ly-6G/Ly-6C, 1:200, Biolegend (San Diego, CA,
USA) 108402) diluted in ready-to-use 2.5% normal goat blocking serum. Next, sections were incubated
for 30 min with ImmPRESS (anti-rat and anti-rabbit) reagent and incubated in peroxidase substrate
working solution. Finally, sections were incubated with Vector Hematoxylin QS nuclear counterstain,
Gill’s Formula (Vector Laboratories Inc., H-3404) and mounted with Vectashield (Vector Laboratories,
H-1000). Quantification of inflammatory infiltrates was performed by computed analysis via Image J.
RGB images were converted to stack images and red, blue, and green channels were separated. Red
intensity should be at least 110% of the blue intensity, surface area and percent neutrophil positive area
was quantified.
5.12. Picrosirius Red Staining
To evaluate the extent of fibrosis, sections were fixed with 4% paraformaldehyde in PBS, stained
with Picrosirius red and examined by light microscopy. Briefly, paraffin embedded sections were
deparaffinated and rehydrated. After repeated washes, slides were incubated in Picrosirius red
working solution pH 2.0 (Picric acid, Sigma-Aldrich (Zwijndrecht, Netherlands), 74069; Sirius Red,
Polysciences, Inc. (Hirschberg an der Bergstrasse, Germany) C.I. 35780) for 60 min. Sections were
directly transferred to 0.01 M HCl solution and incubated under constant movement. Sections were
dehydrated again and a coverslip was placed using Entallan (Merck, Schiphol-Rijk, Netherlands,
107960). Stained sections were scanned at a 40×magnification on a Leica SCN400F Whole Slide Scanner.
Quantification of healthy myocardium was performed by computed analysis of the percentage red
stained tissue with Image J (NIH), which refers to collagen. Regions of interest were selected manually
by lining the tissue of both ventricles and septum. The subepicardial layer was defined as 0.2 mm
tissues underneath the epicardial layer. By means of a macro the fraction of red staining to the total
area was calculated.
5.13. Hematoxylin and Eosin Staining
To evaluate the extent of myocardial damage, sections were fixed with 4% paraformaldehyde in
PBS, stained with hematoxylin and eosin according to the manufacturer’s instructions, and examined
by light microscopy. Briefly, paraffin embedded sections were incubated at 60 ◦C for 30 min. Slides
were incubated in hematoxylin 2 (Thermo Scientific, 7231) for two minutes and directly transferred to
clarifier 2 (Thermo Scientific, 7402) for 15 s. After repeated washes, slides were incubated in a Bluing
reagent (Thermo Scientific, 1931423) for one minute. After a wash, slides were exposed to eosin Y
(Thermo Scientific, 71204) for 1.5 min. After this step the sections were dehydrated again and a coverslip
was placed using Permount Toluene solution. Stained sections were scanned at a 40× magnification
on a Leica SCN400F Whole Slide Scanner. Two independent researchers assessed the subepicardial
damage in HE-stained hearts, by determining the ratio of the non-myocyte area—continuous of the
epicardial layer—to total tissue area. This was done by computed analysis via Image J (NIH) in five
windows of 0.59 mm × 0.31 mm over the ventricular wall; apex, left-ventricular base/mid region, and
right-ventricular base/mid region. The perimeter of the empty area continuous to the epicardial layer
was manually selected (in triplet), excluding myocytes and vessels.
5.14. Statistical Analysis
Statistical analysis and drawing of graphs and plots were carried out in GraphPad Prism (version
6 for Mac OS X, GraphPad Software, San Diego, CA, USA) and SigmaStat 3.5 software. Normality and
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equal variance assumptions were tested with the Kolmogorov-Smirnov and the Levene’s median test,
respectively. Differences between two groups were analyzed using the paired two-tailed Student’s t-test,
comparisons between experimental groups were analyzed by a one-way ANOVA for non-parametric
variables with a Tukey’s post-test for intergroup comparisons. All data is presented as mean ± SEM,
and p < 0.05 was considered significant. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001, and n.s.
p > 0.05. n denotes the number of mice used per dataset.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/17/
4076/s1.
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ACM Arrhythmogenic Cardiomyopathy
AnkB AnkyrinB
BCL Basic cycle length
BW Body weight
Ca2+ Calcium
CaCL2 Calcium chloride
Casq2 Calsequestrin2
Cav1.2 L-type Ca2+ channel
cDNA Complement DNA
CO2 Carbon dioxide
Col1α1 Collagen 1α1
Col1α2 Collagen 1α2
CVL Longitudinal conduction velocity
CVT Transversal conduction velocity
Cx43 Connexin43
EAM Experimental auto-immune myocarditis
ECG Electrocardiogram
GAPDH Glyceraldehyde 3-phosphate dehydrogenase
H&E Hematoxylin and Eosin
HW Heart weight
Hz Heterozygous
IL Interleukin
INa Sodium current
KCL Potassium chloride
LV Left ventricle
LVFS Left ventricular fractional shortening
MgSO4 Magnesium sulfate
MMP9 Matrix metallopeptidase 9
NaCl Sodium chloride
NaH2PO4 Monosodium phosphate
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NaHCO3 Sodium bicarbonate
Nav1.5 Sodium channel
Ncad N-cadherin
NFκ-β Nuclear Factor κ-β
O2 Oxygen
PBS Phosphate buffered saline
PKG Plakoglobin
PKP2 Plakophilin 2
PKP2cKO Plakophilin2 conditional knock out
RT-PCR Reverse transcriptase polymerase chain reaction
RV Right ventricle
RVEF Right ventricular ejection fraction
TAC Trans aortic constriction
TBP TATA binding protein
Timp1 Tissue inhibitor of metalloproteinase 1
TNF Tumor necrosis factor
WT Wildtype
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